7Baggers
Quarterly
Annual
    Unit: USD2023-09-30 2023-06-30 2022-06-30 2019-06-30 2014-09-30 2014-06-30 2012-09-30 2004-09-30 
      
    		        
      cash flows from operating activities:
    		        
      net income
    		291,063 -5,547,070 -1,870,768 4,636,026 -2,229,223 -8,278,871 1,261,404  
      adjustments to reconcile net income to net cash from operating activities:
    		        
      depreciation and amortization
    		530,786 725,069 942,602 1,072,898 2,382,340 3,861,554 1,300,152 481,865 
      provision (reversal) for bad debts
    		        
      gain on sale of assets
    		-98   -15,300     
      stock based compensation
    		60,354 118,892 26,122 150,331     
      changes in operating assets and liabilities:
    		        
      accounts receivable
    		4,608,881 -5,005,084 -2,265,015 2,412,578 -5,723,728 4,701,101  -214,527 
      revenues in excess of billing
    		-1,478,386 1,273,981 -887,722 -3,901,977 133,763    
      other current assets
    		92,686 490,623 416,021 328,781 479,340 71,985  -826,311 
      accounts payable and accrued expenses
    		341,722 -611,531 1,106,390 492,796  -382,026  -564,159 
      unearned revenue
    		-2,791,269 4,220,809 -1,890,726 80,932     
      net cash from operating activities
    		1,663,619 -555,048 -2,465,329 5,188,592 -481,025 3,308,051 2,898,831 -1,062,227 
      capex
    		-371,630 -64,379 -928,349 -136,256 -1,031,128 -3,652,473 -1,457,134 -213,990 
      free cash flows
    		1,291,989 -619,427 -3,393,678 5,052,336 -1,512,153 -344,422 1,441,697 -1,276,217 
      cash flows from investing activities:
    		        
      purchases of property and equipment
    		-371,630 -64,379 -928,349 -136,256 -1,031,128 -3,652,473 -1,457,134 -213,990 
      sales of property and equipment
    		1,230 86,805 27,807 165,664 90,841 27,561 60,501 86,988 
      purchase of subsidiary shares
    		        
      net cash from investing activities
    		-370,400 22,426 -900,542 -938,092 -940,287 -3,851,980 -2,488,599  
      cash flows from financing activities:
    		        
      proceeds from the exercise of stock options and warrants
    		   0  -1 252,900  
      dividend paid by subsidiary to non-controlling interest
    		   0     
      proceeds from bank loans
    		 0 629,374 -109,934 109,211 1,878,156 2,591,135  
      payments on finance lease obligations and loans - net
    		-44,474 -140,519 -224,640      
      net cash from financing activities
    		-44,474 -201,643 -545,618 -542,500 806,721 -446,135 171,628 137,329 
      effect of exchange rate changes
    		-230,322 1,008,022 -2,698,026 -3,356,226 -465,548 69,064   
      net increase in cash and cash equivalents
    		1,018,423  -6,609,515   -921,000 420,181 -666,311 
      cash and cash equivalents at beginning of the period
    		15,533,254 0 0 0     
      cash and cash equivalents at end of period
    		16,551,677 273,757 -6,609,515 351,774     
      (gain) loss on sale of assets
    		     39,778 -14,296  
      proceeds from the exercise of stock options
    		        
      benefit from bad debts
    		7,880 1,695,096 16,491   776,266   
      share of net (gain) income from investment under equity method
    		        
      net decrease in cash and cash equivalents
    		 273,757   -1,080,139    
      goodwill impairment
    		        
      impairment and share of net income from investment under equity method
    		        
      loss on sale of assets
    		  23,333  11,052   620 
      purchase of treasury stock
    		  0      
      purchase of subsidiary treasury stock
    		        
      share of net income from investment under equity method
    		  1,703,899 -1,528     
      gain on forgiveness of loan
    		        
      investment in associates
    		        
      accounts receivable - related party
    		   -516,010 -495,357    
      revenues in excess of billing - related party
    		   -25,451     
      convertible note receivable - related party
    		   -400,000     
      proceeds from exercise of subsidiary options
    		   0  -20,782   
      fair market value of stock options
    		   0     
      impairment of assets
    		        
      payments on capital lease obligations and loans - net
    		   -181,621 -2,591,334 -2,270,018   
      investment in wrld3d
    		        
      purchase of subsidiary shares from open market
    		        
      restricted cash
    		    2,438,844 -33,490 -1,571,442  
      fair market value of warrants and stock options granted
    		    155,622 0 227,926 28,024 
      stock issued for services
    		    290,162 259,193 29,670 25,745 
      cash and cash equivalents, beginning of the period
    		    11,462,695 0   
      cash and cash equivalents, end of period
    		    10,382,556 -921,000  204,850 
      proceeds from sale of common stock
    		    850,000   220,000 
      investment in eegeo
    		        
      purchase of non-controlling interest in subsidiary
    		        
      investment
    		        
      adjustments to reconcile net incometo net cash from operating activities:
    		        
      dividend paid by subsidiary to non controlling interest
    		        
      purchase of non-controlling interest in subsidiaries
    		     0   
      proceeds from stock subscription receivable
    		        
      gain on sale of subsidiary
    		        
      impairment of goodwill
    		        
      sale of subsidiary
    		     0   
      increase in intangible assets
    		     -227,068 -1,091,966  
      unearned revenue - related party
    		        
      share of net income (income) from investment under equity method
    		     175,151   
      accounts payable, accrued expenses and unearned revenue
    		    4,515,004    
      stock issued for interest on notes payable
    		      211,111  
      amortization of financing costs
    		        
      accounts receivable-related party
    		        
      revenue in excess of billing
    		     2,256,931   
      payment to common shareholders for fractional shares
    		        
      supplemental disclosures:
    		        
      cash paid during the period for:
    		        
      interest
    		     104,763 102,198  
      taxes
    		     157,085 24,253  
      non-cash investing and financing activities:
    		        
      stock issued for the payment of vendors
    		     0   
      stock issued for the conversion of convertible notes payable
    		        
      stock issued for the conversion of interest payable
    		        
      (gain) loss on sale of subsidiary
    		        
      beneficial conversion feature
    		      367,744 37,500 
      increase in accounts receivable
    		      -4,320,159  
      decrease in other current assets
    		      1,892,625  
      increase in accounts payable and accrued expenses
    		      1,942,654  
      investment under equity method
    		        
      payment to common shareholders against fractional shares
    		      -194  
      proceeds from convertible notes payable
    		        
      payments on convertible notes payable
    		        
      bank overdraft
    		      59,913  
      payments on capital lease obligations & loans - net
    		      -1,160,684  
      effect of exchange rate changes in cash
    		      -161,679 21,973 
      cash and cash equivalents, beginning of year
    		      7,599,607  
      cash and cash equivalents, end of year
    		      8,019,788  
      stock issued for the conversion of notes payable
    		      1,050,000  
      gain on settlement of finance lease
    		        
      gain on settlement of lease abandonment provision
    		        
      decrease (increase) in accounts receivable
    		        
      increase in other current assets
    		        
      decrease in accounts payable and accrued expenses
    		        
      short-term investments held for sale
    		        
      acquisition, net of cash acquired
    		        
      dividend paid
    		        
      payments on bank loans
    		        
      increase/ decrease in accounts receivable
    		        
      increase/ decrease in other current assets
    		        
      increase/ decrease in accounts payable and accrued expenses
    		        
      loss on foreign currency exchange transaction
    		        
      (gain) on settlement of lease abandonment provision
    		        
      redemption of preferred stock
    		        
      investment in associate
    		        
      stock issued for notes payable and related interest
    		        
      addition to property and equipment
    		        
      disposal of property and equipment
    		        
      cash and cash equivalents, beginning of period
    		       871,161 
      adjustments to reconcile net income
    		        
      to net cash from operating activities:
    		        
      non controlling interest in subsidiary
    		        
      gain on sale of subsidiary shares in pakistan
    		        
      decrease in long-term assets
    		        
      decrease/ increase in accounts payable and accrued expenses
    		        
      payments of acquisition payable
    		        
      purchase of subsidary stock in pakistan
    		        
      proceeds from sale of subsidiary stock
    		        
      loss on foreign currency exchange rates
    		        
      share of net (income)/income from associates
    		        
      (increase)/ decrease in accounts receivable
    		        
      (increase)/ decrease in other current assets
    		        
      increase/ (decrease) in accounts payable and accrued expenses
    		        
      finance costs incurred for sale of common stock
    		        
      loss on transaction of debt
    		        
      stock issued for accrued interest on convertible notes
    		        
      bad debt expense
    		        
      minority interest in subsidiary
    		       -15,068 
      net cash provided by/(used in) operating activities
    		        
      dividend paid to preferred shareholders
    		        
      benefit from uncollectible accounts
    		        
      minority interest in subsidiary - restated in 2008
    		        
      stock based compensation expense
    		        
      beneficial feature of convertible notes payable
    		        
      increase(decrease)in accounts payable and accrued expenses
    		        
      adjustments to reconcile net income to net cash
    		        
      provided by operating activities:
    		        
      purchase of subsidary shares
    		        
      increase in restricted cash
    		        
      net income from continuing operations
    		       34,358 
      used in operating activities:
    		        
      gain on settlement of debt
    		       -50,274 
      increase in assets:
    		        
      decrease in liabilities:
    		        
      purchases of certificates of deposit
    		        
      proceeds from sale of certificates of deposit
    		       250,000 
      increase in intangible assets - development costs
    		       -77,990 
      capital investments in minority interest of subsidiary
    		       191,606 
      proceeeds from sale of minority interest of subsidiary
    		        
      net cash from provided by investing activities
    		       236,614 
      purchase of treasury shares
    		       -51,704 
      proceeds from loans
    		        
      payments on capital lease obligations & loans
    		       -30,967 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.